Sign in Create account

Rajnish Wellness Limited

Healthcare · Pharmaceuticals & Biotechnology

BSE: 541601
₹0.38
▲ 0.00 (0.00%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
21/100
Weak
Valuation
100/100
Undervalued
Momentum
37/100
Neutral

QVM read Cheap on its own multiples Quality Weak, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹39 Cr
PE (TTM)
9.5
Industry median 36.1 (152 companies)
Price to Book
0.4
PEG (TTM)
0.0
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-75.2
Free Cash Flow
₹-9 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
600.00%
as of March 31, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
-20.47%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
281.84%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
-42.79%
as of June 30, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
580.68%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
25.13
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
-1410.67
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
0.40%
as of June 30, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
0.40%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
-4.53%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
0.20%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
-7.08%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
0.21%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.00)
  • No Return on equity is 15% or more (0.2%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

2 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

1 of 3 met
  • No 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

2 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Undervalued (below its own historical PE range))
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
0.0%
Low 0.3700 · High 0.3900
1W return
-2.6%
Low 0.3700 · High 0.3900
1M return
-5.0%
Low 0.3700 · High 0.4100
52W return
-75.2%
Low 0.3700 · High 0.4200
Lifetime High ₹249.5500 (July 19, 2022)
Lifetime Low ₹0.3800 (Sept. 15, 2026)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish0
Bearish6
5D
0.4
10D
0.4
20D
0.5
50D
1.6
100D
3.6
200D
7.2

Delivery and volume

Day avg. delivery
48.2%
Week avg. delivery
57.4%
Month avg. delivery
58.7%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

0.38
Pivot
First resistance0.39
Second resistance0.40
Third resistance0.41
First support0.37
Second support0.36
Third support0.35
Day RSI12.2
Day MFI30.4
Day MACD-0.25
Day MACD signal-0.35

Beta

1M0.53
3M0.60
1Y0.60
3Y0.35

Price change analysis

↓ -5.0%
Over 1 Month
LowHigh
0.370.41
↓ -75.2%
Over 3 Months
LowHigh
0.370.42
↓ -75.2%
Over 6 Months
LowHigh
0.370.42
↓ -75.2%
Over 1 Year
LowHigh
0.370.42
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 9.5 (own history: 38.3–38.3)
Undervalued (below its own historical PE range)

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹31 Cr
Net profit (June 30, 2026)
₹0 Cr
Basic EPS (June 30, 2026)
₹0.0000

Ranks #156 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter9.16%
  • FII/FPI0.43%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 9.16% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings were unchanged at 0.43% in Jun 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 368 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
30 Jun 2026 RIKANT PITTIE Bulk Sell 6,680,000 0.4100 BSE
7 May 2026 JASMITSINGHCHANDHOK Bulk Sell 7,600,000 0.4500 BSE
6 May 2026 JASMITSINGHCHANDHOK Bulk Sell 10,680,378 0.4700 BSE
12 Mar 2026 JASMITSINGHCHANDHOK Bulk Buy 6,556,610 0.5200 BSE
23 Jan 2026 SAROJ KUMAR KUNDU Bulk Sell 5,427,229 0.4800 BSE
13 Jan 2026 SHARE INDIA SECURITIES LIMITED Bulk Buy 5,065,286 0.5200 BSE
13 Jan 2026 SHARE INDIA SECURITIES LIMITED Bulk Sell 5,621,170 0.5100 BSE
12 Jan 2026 SHARE INDIA SECURITIES LIMITED Bulk Sell 6,220,069 0.5000 BSE
12 Jan 2026 SHARE INDIA SECURITIES LIMITED Bulk Buy 7,270,069 0.5100 BSE
26 Dec 2025 RAJPUT RAVINDRA B Bulk Sell 7,500,000 0.5400 BSE

All bulk and block deals →

Corporate Announcements

All 6 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
28 Sep 2026 Insider Trading / SAST Rajnish Wellness Ltd - 541601 - Closure of Trading Window
5 Sep 2026 Company Update Rajnish Wellness Ltd - 541601 - Announcement under Regulation 30 (LODR)-Newspaper Publication
5 Sep 2026 Others Rajnish Wellness Ltd - 541601 - Business Responsibility and Sustainability Reporting (BRSR)
4 Sep 2026 AGM/EGM Rajnish Wellness Ltd - 541601 - Notice Of The 11Th Annual General Meeting Of The Company Scheduled To Be Held Through VC/OAVM On Saturday The 26Th September, 2026
4 Sep 2026 Corp. Action Rajnish Wellness Ltd - 541601 - Intimation Related To Book Closure For The Purpose Of AGM
4 Sep 2026 Others Rajnish Wellness Ltd - 541601 - Reg. 34 (1) Annual Report.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.00)
  • Strong revenue growth YoY (580.7%)

Weaknesses

  • Low Return on Equity (0.2%)
  • Thin net profit margin (0.4%)
  • Declining profit YoY (-42.8%)

Opportunities

  • PEG below 1 (0.02) -- earnings growth outpacing its own valuation
  • PE below 15 (9.5) relative to a typical growth business
  • Trading below book value (PB 0.38)
  • RSI in oversold territory (12.2) -- a technical rebound zone

Threats

  • Down 75.2% over the past year
  • Weak interest coverage (-1410.7x) -- limited cushion against rising rates

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Rajnish Wellness Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.